Stay updated on Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Updated the Publications section to state that PubMed publications are automatically filled in from PubMed, and updated the revision label from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:36.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice. This change does not affect any study details, eligibility criteria, or locations.
    Difference
    0.4%
    Check dated 2025-11-18T07:19:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Adds sponsor/collaborator institutions—Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine—and a new 'Helpful Links Provided by' section.
    Difference
    0.6%
    Check dated 2025-11-03T21:22:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The affiliations for Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and for Washington University School of Medicine, have been removed. The 'Helpful Links Provided by' section is no longer displayed.
    Difference
    0.2%
    Check dated 2025-10-27T20:39:38.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:55:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Removed a specific resource entry for a disease and updated the page version to v3.1.0.
    Difference
    0.5%
    Check dated 2025-09-29T03:13:27.000Z thumbnail image

Stay in the know with updates to Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab+Pembrolizumab in Recurrent Head & Neck Cancer Clinical Trial page.